Craig Eckfeldt, MD, PhD

Hematologist Oncologist, Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation

location_city M Health Fairview Masonic Cancer Clinic

Clinical Expertise

Developing novel targeted and immune therapy approaches for acute myeloid leukemia (AML). The goal of the research in Dr. Eckfeldt's lab is to investigate the genetics and signaling pathways that drive acute myeloid leukemia (AML) to provide a foundation for the development of novel targeted and immune treatment approaches for AML. His research is focused on identifying the critical pathways that drive AML growth and survival, evaluating the effects of targeted therapies in preclinical cancer models, and studying how targeted therapies influence the susceptibility of cancer cells to immune therapies such as Natural Killer (NK) cell immunotherapy, an area of institutional expertise.